PRINCETON, N.J., Oct. 05, 2023 CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification,.
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PRINCETON, N.J., Sept. 19, 2023 CytoSorbents Corporation , a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly.
In the first human retrospective study, CytoSorb and ex vivo lung perfusion prior to lung transplant increased in-hospital and one-year survivalPRINCETON, N.J., Sept. 11, 2023 CytoSorbents.